Antivirals study done during Omicron shows reduced risk of death

+Print Archive

News

Antivirals study done during Omicron shows reduced risk of death

26 October 2022

Amanda Cameron

Wednesday 26 October 2022, 03:15 AM

Oral PI_box and placebo pills_CR_Pfizer.jpeg

Early initiation of COVID antivirals in the community reduced the risks of deteriorating in hospital and dying, says a study in The Lancet [Pfizer]

A large study of the real-world effectiveness of oral antivirals against COVID-19 broadly supports the research findings that underpinned their regula

Research

References

Wong CKH, Au ICH, Lau KTK, et al. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study. The Lancet 2022; 400(10359):1213–1222.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539539/

Print Archive

How to Treat

Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management

Wednesday 14 August 2024, 12:45 AM